Fuso Pharmaceutical Industries (TSE:4538) ROC %: 0.00% (As of Mar. 2026)


TSE:4538 Fuso Pharmaceutical Industries Ltd TSE:4538
51 GF Score
Price 円2,071.00
GF Value 円2,540.99
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Fuso Pharmaceutical Industries ROC %?

Fuso Pharmaceutical Industries TSE:4538 +0.34% 51 ROC % is 0.00% as of Mar. 2026. GuruFocus rates TSE:4538 with a GF Score™ of 51/100 and a GF Value™ of 円2,540.99 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Fuso Pharmaceutical Industries's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was 0.00%.

As of today (2026-06-27), Fuso Pharmaceutical Industries's WACC % is 1.52%. Fuso Pharmaceutical Industries's ROC % is 1.24% (calculated using TTM income statement data). Fuso Pharmaceutical Industries earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Fuso Pharmaceutical Industries  (TSE:4538) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Fuso Pharmaceutical Industries's WACC % is 1.52%. Fuso Pharmaceutical Industries's ROC % is 1.24% (calculated using TTM income statement data). Fuso Pharmaceutical Industries earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Fuso Pharmaceutical Industries ROC % Related Terms


Fuso Pharmaceutical Industries ROC % Historical Data

* Premium members only.

The historical data trend for Fuso Pharmaceutical Industries's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuso Pharmaceutical Industries ROC % Chart

Fuso Pharmaceutical Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.76 2.88 2.58 4.10 2.94

Fuso Pharmaceutical Industries Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Mar26
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.74 0.00 2.25 2.70 0.00
TSE:4538
51GF Score
Fuso Pharmaceutical Industries Ltd TSE:4538
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuso Pharmaceutical Industries ROC % Calculation

Fuso Pharmaceutical Industries's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2026 is calculated as:

ROC % (A: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2025 ) + Invested Capital (A: Mar. 2026 ))/ count )
=2640 * ( 1 - 17.47% )/( (71407 + 77043)/ 2 )
=2178.792/74225
=2.94 %

where

Fuso Pharmaceutical Industries's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=0 * ( 1 - 0% )/( (76251 + 77043)/ 2 )
=0/76647
=0.00 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 0.00% mean?
Fuso Pharmaceutical Industries (TSE:4538) has a ROC % of 0.00% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Fuso Pharmaceutical Industries and its competitors.
Is Fuso Pharmaceutical Industries' ROC % too high?
Fuso Pharmaceutical Industries' current ROC % is 0.00%. Overall, Fuso Pharmaceutical Industries has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fuso Pharmaceutical Industries' ROC % compare to ZTS?
Fuso Pharmaceutical Industries' ROC % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median ROC % is 4.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Drug Manufacturers company?
The median ROC % among Drug Manufacturers companies is 4.44, based on 985 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Fuso Pharmaceutical Industries and its competitors. For the Drug Manufacturers industry, the median ROC % is 4.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fuso Pharmaceutical Industries's current ROC % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuso Pharmaceutical Industries stock overvalued right now?
Based on GuruFocus' analysis, Fuso Pharmaceutical Industries (TSE:4538) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,540.99, compared to a current price of 円2,071.00 — trading 18.5% below its estimated fair value. The current ROC % is 0.00%. Fuso Pharmaceutical Industries' overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Fuso Pharmaceutical Industries (TSE:4538), the current ROC % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuso Pharmaceutical Industries (TSE:4538) Overvalued in 2026?

Based on GuruFocus' analysis, Fuso Pharmaceutical Industries stock appears to be undervalued. The current stock price of 円2,071.00 is trading 18.5% below its estimated GF Value™ of 円2,540.99. GuruFocus considers Fuso Pharmaceutical Industries to be Modestly Undervalued.

Key valuation signals for TSE:4538:

  • ROC %: 0.00%
  • GF Value™: 円2,540.99 vs. price of 円2,071.00 (18.5% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the TSE:4538 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fuso Pharmaceutical Industries Business Description

Address No. 10, No. 7-chome Doshomachi, Chuo-ku, OsaKa, JPN, 541-0045
Fuso Pharmaceutical Industries Ltd. is engaged in the manufacture and sale of pharmaceuticals and medical equipment. The company's main products are transfusion fluid and artificial kidney dialysis fluid. Company also includes real estate segment.
51GF Score

Get the complete analysis for TSE:4538

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,071.00
Price
円2,540.99
GF Value